Brief: Sun Pharma Advanced Research March-Quarter Consol Profit 17.61 Billion Rupees
May 18 (Reuters) - Sun Pharma Advanced Research Co Ltd SPRC.NS: SUN PHARMA ADVANCED RESEARCH MARCH-QUARTER CONSOL PROFIT 17.61 BILLION RUPEES SUN PHARMA ADVANCED RESEARCH MARCH-QUARTER CONSOL TOTAL REVENUE FROM OPERATIONS 18.53 BILLION RUPEES Source text: [ID:] Further company coverage: SPRC.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Sun Pharma Advanced Research
See all newsAdvisory: Alert incorrectly tagged to Sun Pharma Advanced Research withdrawn
Brief: Sun Pharma Advanced Research Appoints Anil Raghavan As MD And CEO Effective August 11
Brief: Sun Pharma Advanced Research Says Ocuvex Therapeutics Gets Complete Response Letter For PDP-716 NDA
India's Sun Pharma Advanced Research jumps after swinging to Q4 profit
Brief: Sun Pharma Advanced Research March-Quarter Consol Profit 17.61 Billion Rupees